MCAM and ovarian carcinoma: We offered solid evidence to strongly suggest that METCAM/MUC18 is a new suppressor for the tumorigenesis and malignant propensity of the two human ovarian carcinoma cell lines, SK-OV-3 and BG-1 [23,24].